Subclinical lipohypertrophy——Easily ignored complications of insulin therapy
- 26 November 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Diabetes and its Complications
- Vol. 35 (3), 107806
- https://doi.org/10.1016/j.jdiacomp.2020.107806
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
- Jiangsu Provincial Commission of Health and Family Planning
This publication has 36 references indexed in Scilit:
- IntroductionDiabetes Care, 2014
- Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetesDiabetes & Metabolism, 2013
- Evidence of a Strong Association Between Frequency of Self-Monitoring of Blood Glucose and Hemoglobin A1c Levels in T1D Exchange Clinic Registry ParticipantsDiabetes Care, 2013
- Lypohypertrophy in patients receiving insulin therapy: state of the artDiabetes mellitus, 2011
- Effect of Glycemic Exposure on the Risk of Microvascular Complications in the Diabetes Control and Complications Trial—RevisitedDiabetes, 2008
- Incidence of lipohypertrophy in diabetic patients and a study of influencing factorsDiabetes Research and Clinical Practice, 2007
- Skin-Related Complications of Insulin TherapyAmerican Journal of Clinical Dermatology, 2003
- Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factorsExperimental and Clinical Endocrinology & Diabetes, 1996
- Relationship Between Absorption of Radiolabeled Soluble Insulin, Subcutaneous Blood Flow, and AnthropometryDiabetes Care, 1992
- Diabetic Lipohypertrophy Delays Insulin AbsorptionDiabetes Care, 1984